InfraRdDx gets FDA clearance for LipiScan Coronary Imaging System

04/28/2008 | NYTimes.com

Federal regulators have cleared InfraRdDx's LipiScan Coronary Imaging System, a laser scanning device designed to detect fatty deposits in blood vessel walls. The product could help physicians when implanting stents in vessels, the company said.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID